Dermatology clinical trials depend on eCOA to align investigator grading, patient-reported symptoms such as itch and pain, photographic documentation, and the visit-level data that surrounds them, as disease presentation changes visibly over time.
These trials are subjective by design. Skin disease presents differently across skin tones and phototypes, severity can shift between visits, and the symptoms that matter most to patients are the hardest to standardize. When assessment drifts, the impact lands on the endpoint: rater variability, missing images, and reconciliation work that arrives too late to correct.
Strong outcomes require eCOA built for visual assessments with standardized scoring, protocol-aligned image capture, and audit-ready data collection that holds at global scale.
Why Dermatology Trials
Require Specialized eCOA
Expand your capabilities without expanding headcount. YPrime brings nearly two decades of specialized eCOA expertise to visual and symptom-based endpoints. Our therapeutic area knowledge, instrument licensing relationships, and global regulatory experience fill critical gaps in your portfolio — so you can pursue new dermatology opportunities with a complete technology suite that covers the full patient journey.
Align investigator grading, symptom PROs, and photographic assessment
Automate scale scoring requirements to assess changes over time
Capture protocol-aligned images with full audit traceability
eCOA Case Study:
Proven in Global Dermatology Study
Challenge
A biotechnology company developing an oral therapy for moderate-to-severe plaque psoriasis needed to run a large Phase 3 extension study at global scale. The program required consistent investigator grading across hundreds of sites, frequent visual assessment, and the ability to absorb ongoing program change without disrupting execution.
YPrime Solution
YPrime configured a purpose-built eCOA solution to carry the program at scale:
- Deployed assessments capturing affected body surface area and disease severity
- Supported more than 1,500 patients across 270+ sites in 11 countries and 15 languages
- Built automated calculation logic that translated scores into dosing guidance and rescue-treatment decisions
- Provisioned 300+ tablets to remove device variability from grading
Outcome
The study met all primary and secondary endpoints with high statistical significance, exceeded enrollment goals, and completed ahead of schedule. Automated calculation eliminated manual work at the site level while preserving full auditability and inspection readiness across every region.
How YPrime Supports Dermatology Studies
YPrime delivers high-quality, flexible eCOA for global dermatology programs across inflammatory, pigmentary, and aesthetic indications. Our experience supporting dermatology trials, including psoriasis and atopic dermatitis, is grounded in practical, study-proven execution:
Support for PASI, EASI, IGA, DLQI, and NRS, plus the depression and suicidality assessments dermatology protocols require
Protocol-aligned image capture by anatomical region, traceable to visit, assessment, administrator, device, and timestamp
Visual scoring with reference images embedded directly in the assessment
Body-map interfaces with 50+ region points for symptom reporting and real-time flare entry
Global language support, translation management, and instrument licensing expertise
eCOA Designed for Participants, Sponsors, and Sites
Dermatology trials require clarity at every level of execution. Participants need intuitive workflows for symptom reporting, image capture, body-map activities, and diary completion. Sites need real-time insight into assessment completion, missing images, and grading consistency. This alignment reduces friction and strengthens data quality across the study lifecycle.
Power Your Next Dermatology Clinical Trial
Whether launching a global psoriasis study, optimizing an active atopic dermatitis trial, or planning your next dermatology program, the right eCOA foundation enables consistent execution at scale.
Start the conversation with our eCOA experts to see how YPrime supports dermatology clinical trials with the quality and flexibility these studies demand.
FAQs
eCOA (electronic Clinical Outcome Assessment) is used to collect patient-reported symptoms, investigator assessments, and study data electronically. In dermatology clinical trials it supports symptom diaries, visual scoring, photographic workflows, and protocol-defined activities in place of paper — improving accuracy and reducing missing entries.
Dermatology studies combine patient-reported symptoms, investigator grading, and photographic assessment. eCOA standardizes how each is collected, improves consistency across sites and raters, and maintains audit-ready documentation throughout the study.
YPrime’s eCOA platform supports PASI, EASI, IGA, DLQI, and NRS measures, along with symptom diaries, body-map workflows, photographic assessment, and the depression and suicidality instruments often required in dermatology protocols.
YPrime’s eCOA platform supports protocol-aligned image capture by anatomical region, photographic references for scoring and grading, audit trails for every image upload, and traceability across visit, assessment, administrator, device, and timestamp.